Uses and limitations of monoclonal antibodies (MoAbs) in the treatment of malignant disease: a review.
Kemshead
J T
JT
Imperial Cancer Research Fund, Frenchay Hospital, Bristol.
Hopkins
K
K
D000818:Animals; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use*; D004306:Dose-Response Relationship, Immunologic; D006801:Humans; D000922:Immunotoxins / Q000008:administration & dosage / Q000627:therapeutic use; D015552:Injections, Intralesional; D051379:Mice; D009369:Neoplasms / Q000378:metabolism / Q000628:therapy*; D051381:Rats
D000911:Antibodies, Monoclonal; D000922:Immunotoxins